Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


Articles published in Int Urol Nephrol

Retrieve available abstracts of 29 articles:
HTML format
Text format



Single Articles


    July 2017
  1. VAN DE PUTTE EEF, Vegt E, Mertens LS, Bruining A, et al
    FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy.
    Int Urol Nephrol. 2017 Jul 3. doi: 10.1007/s11255-017-1637.
    PubMed     Text format     Abstract available


    March 2017
  2. BOTHIG R, Kurze I, Fiebag K, Kaufmann A, et al
    Clinical characteristics of bladder cancer in patients with spinal cord injury: the experience from a single centre.
    Int Urol Nephrol. 2017 Mar 22. doi: 10.1007/s11255-017-1570.
    PubMed     Text format     Abstract available


  3. YAMASHITA R, Watanabe R, Ito I, Shinsaka H, et al
    Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Int Urol Nephrol. 2017;49:425-430.
    PubMed     Text format     Abstract available


    February 2017
  4. SONG W, Jeon HG, Jeong BC, Seo SI, et al
    Clinical significance of incidentally detected bladder wall thickening on computed tomography.
    Int Urol Nephrol. 2017;49:191-196.
    PubMed     Text format     Abstract available


  5. GONDO T, Ohno Y, Nakashima J, Hashimoto T, et al
    Preoperative determinant of early postoperative renal function following radical cystectomy and intestinal urinary diversion.
    Int Urol Nephrol. 2017;49:233-238.
    PubMed     Text format     Abstract available


    January 2017
  6. MAHMOUD O, El-Assmy A, Kamal M, Ashamallah A, et al
    Is chronic alkali therapy in orthotopic ileal neobladders necessary? A prospective controlled study.
    Int Urol Nephrol. 2017;49:49-53.
    PubMed     Text format     Abstract available


    December 2016
  7. OTTO W, Breyer J, Herdegen S, Eder F, et al
    WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach.
    Int Urol Nephrol. 2016 Dec 29. doi: 10.1007/s11255-016-1491.
    PubMed     Text format     Abstract available


    November 2016
  8. MAY M, Protzel C, Vetterlein MW, Gierth M, et al
    Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.
    Int Urol Nephrol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  9. LI HM, Azhati B, Rexiati M, Wang WG, et al
    Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  10. MAURICE MJ, Kim SP, Abouassaly R
    Socioeconomic status is associated with urinary diversion utilization after radical cystectomy for bladder cancer.
    Int Urol Nephrol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  11. TONYALI S, Yazici S
    Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?
    Int Urol Nephrol. 2016;48:671-80.
    PubMed     Text format     Abstract available


    April 2016
  12. JO JK, Jeong SJ, Hong SK, Byun SS, et al
    The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Int Urol Nephrol. 2016;48:489-94.
    PubMed     Text format     Abstract available


  13. ROBINSON R, Tait CD, Somov P, Lau MW, et al
    Estimated glomerular filtration rate is unreliable in detecting renal function loss during follow-up after cystectomy and urinary diversion.
    Int Urol Nephrol. 2016;48:511-5.
    PubMed     Text format     Abstract available


    March 2016
  14. LI CE, Chien CS, Chuang YC, Chang YI, et al
    Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  15. ZHANG J, Shi Z, Nan Y, Li M, et al
    Inhibiting malignant phenotypes of the bladder cancer cells by silencing long noncoding RNA SChLAP1.
    Int Urol Nephrol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  16. XIE J, Zhang XB, Wen J, Zhang YS, et al
    Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer.
    Int Urol Nephrol. 2016.
    PubMed     Text format     Abstract available


  17. SATO Y, Kondo T, Takagi T, Junpei I, et al
    Treatment strategy for bladder cancer in patients on hemodialysis: a clinical review of 28 cases.
    Int Urol Nephrol. 2016.
    PubMed     Text format     Abstract available


  18. WANG L, Zhou M, Feng C, Gao P, et al
    Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy.
    Int Urol Nephrol. 2016.
    PubMed     Text format     Abstract available


    September 2015
  19. THOMAS C, Giesswein A, Hainz M, Stein R, et al
    Concomitant Gleason Score >/=7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy.
    Int Urol Nephrol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  20. KOIE T, Ohyama C, Hosogoe S, Yamamoto H, et al
    Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  21. XU T, Zhu Z, Wang X, Xia L, et al
    Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer.
    Int Urol Nephrol. 2015.
    PubMed     Text format     Abstract available


  22. ANDER H, Donmez MI, Yitgin Y, Tefik T, et al
    Urothelial carcinoma of the urinary bladder in pediatric patients: a long-term follow-up.
    Int Urol Nephrol. 2015;47:771-4.
    PubMed     Text format     Abstract available


    April 2015
  23. DJUKIC T, Simic T, Radic T, Matic M, et al
    GSTO1*C/GSTO2*G haplotype is associated with risk of transitional cell carcinoma of urinary bladder.
    Int Urol Nephrol. 2015;47:625-30.
    PubMed     Text format     Abstract available


    February 2015
  24. AHMED FO, Hamdan HZ, Abdelgalil HB, Sharfi AA, et al
    A comparison between transabdominal ultrasonographic and cystourethroscopy findings in adult Sudanese patients presenting with haematuria.
    Int Urol Nephrol. 2015;47:223-8.
    PubMed     Text format     Abstract available


    January 2015
  25. FLOYD MS JR, Khattak AQ
    Total urinary tract exenteration including donor nephrectomy for transitional cell carcinoma 41 years following transplantation.
    Int Urol Nephrol. 2015;47:107-8.
    PubMed     Text format    


  26. WILLIAMS EM, Higgins JP, Sangoi AR, McKenney JK, et al
    Androgen receptor immunohistochemistry in genitourinary neoplasms.
    Int Urol Nephrol. 2015;47:81-5.
    PubMed     Text format     Abstract available


    August 2014
  27. HUANG TB, Guo ZF, Zhang XL, Zhang XP, et al
    Coffee consumption and urologic cancer risk: a meta-analysis of cohort studies.
    Int Urol Nephrol. 2014;46:1481-93.
    PubMed     Text format     Abstract available


  28. SUER E, Ozcan C, Gokce I, Gulpinar O, et al
    Do blood groups have effect on prognosis of patients undergoing radical cystectomy?
    Int Urol Nephrol. 2014;46:1521-6.
    PubMed     Text format     Abstract available


  29. YE J, Xu X, Fan M, Xue D, et al
    AFP-producing urothelial carcinoma of the bladder: a case report.
    Int Urol Nephrol. 2014;46:1527-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: